Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
694
-
Total 13F shares, excl. options
-
264M
-
Shares change
-
+260M
-
Total reported value, excl. options
-
$7.78B
-
Value change
-
+$7.65B
-
Put/Call ratio
-
0.55
-
Number of buys
-
647
-
Number of sells
-
-52
-
Price
-
$29.43
Significant Holders of GSK plc - SPONSORED ADR (GSK) as of Q3 2022
748 filings reported holding GSK - GSK plc - SPONSORED ADR as of Q3 2022.
GSK plc - SPONSORED ADR (GSK) has 694 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 264M shares
.
Largest 10 shareholders include Dodge & Cox (58.6M shares), FMR LLC (14.1M shares), Fisher Asset Management, LLC (12.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.2M shares), Capital International Investors (11.1M shares), RENAISSANCE TECHNOLOGIES LLC (9.35M shares), GOLDMAN SACHS GROUP INC (8.06M shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (8.05M shares), STATE STREET CORP (7.57M shares), and TWO SIGMA INVESTMENTS, LP (7.14M shares).
This table shows the top 694 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.